Physician
Bagam, Samatha
Bagam, Samatha was paid $359K by Medicaid between Jan 2018 and Nov 2023, across 20 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 43% of everything it billed.
33Billing provider infoBAGAM, SAMATHA
MIDDLETOWN, NY 10941
MIDDLETOWN, NY 10941
33aNPI1518186840assigned 04/25/2007
33bProvider typePediatrics Physician
28Total paid$359K
24GClaims5,874
24DCodes billed20
24AFirst – last monthJan 2018 – Nov 2023
Compared with peers
Next to other Pediatrics Physician providers in New York
Rank by total paid#484 of 1,983
Median peer was paid$17K
This provider vs. median21×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 182 | $11K | |
| 2019 | 996 | $45K | |
| 2020 | 1,238 | $66K | |
| 2021 | 1,339 | $97K | |
| 2022 | 1,944 | $127K | |
| 2023 | 175 | $14K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 43% | 1,671 | 1,580 | $153K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 22% | 686 | 669 | $78K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 12% | 319 | 317 | $43K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 8.3% | 261 | 261 | $30K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 7.2% | 1,257 | 1,249 | $26K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 3.1% | 97 | 97 | $11K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 2.2% | 62 | 62 | $8K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 26 | 26 | $3K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 36 | 36 | $2K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 44 | 43 | $2K |
| 87634 | <1% | 14 | 14 | $982.80 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 36 | 36 | $825.00 |
8 more codes
| 96127 | <1% | 119 | $669.51 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 27 | $429.78 |
| 92551 | <1% | 533 | $347.29 | |
| 90686 | <1% | 507 | $288.52 | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 13 | $167.22 |
| 85018 | <1% | 51 | $123.55 | |
| 99173 | 0% | 63 | $0.00 | |
| 36416 | 0% | 52 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.